EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

05.12.18

The EPO’s ‘Inventor Award’ Scam: Part II

Posted in Deception, Europe, Patents at 12:08 am by Dr. Roy Schestowitz

Andane Remmal

Summary: The sorts of people whom Battistelli’s EPO grants awards to are sometimes literal frauds and sometimes people who, according to domain experts, did not even deserve the patent they got a prize for

THE EPO is a highly abusive organisation. We’d go further and say corrupt, albeit that typically leads the EPO to trying to SLAPP us. We have never ever seen anything remotely like it at the USPTO, which is reasonably professional. We focus on patent scope there (this has improved in recent years). The USPTO maintains neutrality on patents; no rankings or “awards” (a form of special endorsement)…

EPO insiders can’t stop talking about next month’s event, which will be the passage of EPO budget to Saint-Germain-en-Laye.

As one comment put it a couple of days ago: “Hadn’t you noticed that the EPO is currently under the – I am almost tempted to add “totalitarian” – political control of the deputy mayor of Saint-Germain-en-Laye?”

Does nobody in the mainstream media see the problem with that? It’s not only against the rules (for public servants in international institutions); putting aside the passage of EPO money to Saint-Germain-en-Laye…

“Does nobody in the mainstream media see the problem with that? It’s not only against the rules (for public servants in international institutions); putting aside the passage of EPO money to Saint-Germain-en-Laye…”The remark is in the fifth comment by the way, responding to “MaxDrei” (mentioned/quoted here in relation to its context).

But this post is not about the scandal of Battistelli’s ‘alleged’ misuse of budget or even the award to a literal fraud (whom the EPO now tries to distance itself from — very, very belatedly). This post relates to our first part, which spoke about Morocco, a former French colony which Battistelli seems to be oftentimes leveraging for political agenda. This post is about award for EP1879655B1 (“Advanced [sic] Scientific [sic] Developments” [sic] led by Mr. Remmal).

How much of an invention was it really? Someone who is familiar with this scientific domain looked more closely at it. I should disclose that it’s well outside my field of specialty, so I mostly rely on others for this assessment, which was carried out anonymously.

“How much of an invention was it really?”“It is about the mentioned patent granted to Remmal,” told us a source, “who got the EPO inventor award last year.

“In my opinion there was a lot ado about nothing in the Gazette.”

There was an article about it the Gazette, in French even! [Page 1, Page 2]

“In the present case I am not questioning the probity of Mr. Remmal,” our source said, “but he is definitely NOT the genius that the EPO makes out of him.

“Clinical phytotherapy is a research field since the early 70s. Synergistic effects were investigated with antibiotics alone, and are the basis of aromatherapy. Yet the combination of essential oils and antibiotics and corresponding synergistic effects have been disclosed in 2003 already. See this publication: Bacterial resistance modifying agents from Lycopus europaeus.”

From the Abstract: “As part of an ongoing project to identify plant natural products which modulate bacterial multidrug resistance (MDR), bioassay-guided isolation of an extract of Lycopus europaeus yielded two new isopimarane diterpenes, namely methyl-1alpha-acetoxy-7alpha 14alpha-dihydroxy-8,15-isopimaradien-18-oate (1) and methyl-1alpha,14alpha-diacetoxy-7alpha-hydroxy-8,15-isopimaradien-18-oate (2). The structures were established by spectroscopic methods. These compounds and several known diterpenes were tested for in vitro antibacterial and resistance modifying activity against strains of Staphylococcus aureus possessing the Tet(K), Msr(A), and Nor(A) multidrug resistance efflux mechanisms. At 512 microg/ml none of the compounds displayed any antibacterial activity but individually in combination with tetracycline and erythromycin, a two-fold potentiation of the activities of these antibiotics was observed against two strains of S. aureus that were highly resistant to these agents due to the presence of the multidrug efflux mechanisms Tet(K) (tetracycline resistance) and Msr(A) (macrolide resistance).

Our source continued to stress “that predates the priority date. (2005). Note that this document wasn’t cited – unfortunately – in the search report. This document does not quote carvacrol, carveol or alpha-ionone as constituents of essential oils. But carvacrol and carveol were already known at that time for their antibiotic effect . I see no inventive step there. In my opinion the inventor of the year 2017 was awarded a prize on the basis of an unduly granted patent.”

Research into this has gone on for at least a week. It’s not a rushed judgment. As our source put it, having consulted others as well, “the more I look into the Remmal case, the more I believe we have explosive material. I had the document I referred to double-checked by a specialist and yes I can say that the granted claims do not have the required inventive step.

“But there is more than that. The company owned by Mr.Remmal, Advanced Scientific Developments, is an asset management firm (gestion de valeur mobilere).”

On the day of the priority date (13/5/2005) Mr. Remmal filed 4 applications, namely:

  • US20080171709A1: Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an anti-parasitic agent, and active agent selected among carveol, thymol, eugenol, borneol and carvacrol.
  • US20080214568A1: pharmaceutical combination comprising an antifungal agent and an active substance selected from carveol, eugenol, thymol, borneol, carvacrol, and alpha- and beta-ionones.
  • US20080171768A1: pharmaceutical composition containing an anti-parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone.
  • US20080214518A1: pharmaceutical composition comprising an antibacterial agent and an active ingredient selected from carveol, thymol, eugenol, borneol and carvacrol.

“The last one in its EPO version is the patent on which Remmal received the “inventor” award,” our source remarked. “On all 4 patents the addition of essential oils exhibits a notable synergistic effect, not only with antibiotics but also with antifungal, anti-parasitic, anti-tumoral, antiviral agents. If all this was true, Mr. Remmal would deserve a Nobel prize, not just a dubious EPO inventor award prize.”

“I have also checked the publications by Remmal,” the source noted. “The number and scope of the publications is an indicator of a scientist’s activity. Here is a list. What I see are many publications in the field of essential oils and their medical uses. All these papers are published by Remmal at al but none deals with the use of essential oils in combination with other medications. I find very awkward that none of the publications addresses the subject for which the EP patent was applied for.

“To close the subject, an article published just after Mr. Remmal was awarded the EPO inventor prize [is] a very touching article that looks more like self promotion. I don’t want to judge someone without having an in-depth knowledge of the situation, but considering all the facts I have made my opinion and it is not positive. Frankly, I believe that Remmal is just another troll. What do you think?”

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Florian Müller's Article About SEPs and the EPO

    Report from the court in Munich, where the EPO is based



  2. EPO Vice-President Željko Topić in New Article About Corruption in Croatia

    The Croatian newspaper 7Dnevno has an outline of what Željko Topić has done in Croatia and in the EPO in Munich; it argues that this seriously erodes Croatia's national brand/identity



  3. The Quality of European Patents Continues to Deteriorate Under António Campinos and Software Patents Are Advocated Every Day

    The EPC in the European Patent Office and 35 U.S.C. § 101 in the USPTO annul most if not all software patents; under António Campinos, however, software patents are being granted in Europe and the USPTO exploits similar tricks



  4. Team UPC is Still Spreading False Rumours in an Effort to Trick Politicians and Pressure Judges

    Abuses at the European Patent Office, political turmoil and an obvious legislative coup by a self-serving occupation that produces nothing have already doomed the Unitary Patent or Unified Patent Court (UPC); so now we deal with complete fabrications from Team UPC as they're struggling to make something out of nothing, anonymously smearing opposition to the UPC and anonymously making stuff up



  5. Patents on Life and Patents That Kill the Poor Would Only Delegitimise the European Patent Office

    After Mayo, Myriad and other SCOTUS cases (the basis of 35 U.S.C. § 101) the U.S. Patent and Trademark Office is reluctant to grant patents on life; the European Patent Office (EPO), however, goes in the opposite direction, even in defiance of the European Patent Convention



  6. EPO 'Untapped Potential'

    "Campinos is diligently looking for ways to further increase the Office’s output without increasing the number of examiners," says the EPO-FLIER team



  7. Links 9/12/2018: New Linux Stable Releases (Notably Linux 4.19.8), RC Coming, and Unifont 11.0.03

    Links for the day



  8. Links 8/12/2018: Mesa 18.3.0, Mageia 7 Beta, WordPress 5.0

    Links for the day



  9. The European Patent Organisation is Like a Private Club and Roland Grossenbacher is Back in It

    In the absence of Benoît Battistelli quality control at the EPO is still not effective; patents are being granted like the sole goal is to increase so-called 'production' (or profit), appeals are being subjected to threats from Office management, and external courts (courts that assess patents outside the jurisdiction of the Office/Organisation) are being targeted with a long-sought replacement like the Unified Patent Court, or UPC (Unitary Patent)



  10. Links 7/12/2018: GNU Guix, GuixSD 0.16.0, GCC 7.4, PHP 7.3.0 Released

    Links for the day



  11. The Federal Circuit's Decision on Ancora Technologies v HTC America is the Rare Exception, Not the Norm

    Even though the PTAB does not automatically reject every patent when 35 U.S.C. § 101 gets invoked we're supposed to think that somehow things are changing in favour of patent maximalists; but all they do is obsess over something old (as old as a month ago) and hardly controversial



  12. The European Patent Office Remains a Lawless Place Where Judges Are Afraid of the Banker in Chief

    With the former banker Campinos replacing the politician Battistelli and seeking to have far more powers it would be insane for the German Constitutional Court to ever allow anything remotely like the UPC; sites that are sponsored by Team UPC, however, try to influence outcomes, pushing patent maximalism and diminishing the role of patent judges



  13. Many of the Same People Are Still in Charge of the European Patent Office Even Though They Broke the Law

    "EPO’s art collection honoured with award," the EPO writes, choosing to distract from what actually goes on at the Office and has never been properly dealt with



  14. Links 6/12/2018: FreeNAS 11.2, Mesa 18.3 Later Today, Fedora Elections

    Links for the day



  15. EPO, in Its Patent Trolls-Infested Forum, Admits It is Granting Bogus Software Patents Under the Guise of 'Blockchain'

    Yesterday's embarrassing event of the EPO was a festival of the litigation giants and trolls, who shrewdly disguise patents on algorithms using all sorts of fashionable words that often don't mean anything (or deviate greatly from their original meanings)



  16. The Patent Litigation Bubble is Imploding in the US While the UPC Dies in Europe

    The meta-industry which profits from feuds, disputes, threats and blackmail isn't doing too well; even in Europe, where it worked hard for a number of years to institute a horrible litigation system which favours global plaintiffs (patent trolls, opportunists and monopolists), these things are going up in flames



  17. Links 5/12/2018: Epic Games Store, CrossOver 18.1.0, Important Kubernetes Patch

    Links for the day



  18. Links 4/12/2018: LibrePCB 0.1.0, SQLite 3.26.0, PhysX Code

    Links for the day



  19. EPO Management Keeps Embarrassing Itself, UPC More Dead Than Before, and Nokia Turns Aggressive

    The EPO’s race to the bottom of patent quality continues, it’s now complemented by direct association with patent trolls and law stands in their way (for they repeatedly violate the law)



  20. The Intellectual Property Owners Association (IPO) and IBM Are Part of the Software Patents Problem in the United States

    IBM's special role in lobbying for software patents (and against PTAB) needs to be highlighted; even Ethereum’s co-founder isn't happy about IBM's meddling in the blockchain space (with help from Hyperledger/Linux Foundation)



  21. The Patent Trial and Appeal Board (PTAB) Not Falling for Attempts to Prevent It From Instituting Challenges

    In the face of patent maximalists' endless efforts to derail patent quality the tribunal keeps calm and carries on smashing bad patents



  22. Links 2/12/2018: Linux 4.20 RC5, Snapcraft 3.0, VirtualBox 6.0 Beta 3

    Links for the day



  23. The Patent Microcosm Hopes That the Federal Circuit Will Get 'Tired' of Rejecting Software Patents

    Trolls-friendly sites aren't tolerating this court's habit of saying "no" to software patents; the Chief Judge meanwhile acknowledges that they're being overrun by a growing number of cases/appeals



  24. 35 U.S.C. § 101 Continues to Crush Software Patents and Even Microsoft Joins 'the Fun'

    The Court of Appeals for the Federal Circuit (CAFC) and even courts below it continue to throw out software patents or send them back to PTAB and lower courts; there is virtually nothing for patent maximalists to celebrate any longer



  25. The Anti-Section 101 (Pro-Software Patents) Lobby Looks at New Angles for Watering Down Guidelines and Caselaw

    By focusing on jury trials and patent trolls the proponents of bunk, likely-invalid abstract patents hope to overrule or override technical courts such as the Patent Trial and Appeal Board (PTAB)



  26. Patent Trolls, USPTO Director Andrei Iancu and Section 101

    The world’s most important patent office is now run by a courts-hostile person (an 'American Battistelli') who is happy to ignore the courts’ caselaw and listen to patent trolls instead; this means that science and technology, not to mention the law itself, will suffer



  27. Be Wary of the Latest Lies About the Unified Patent Court (UPC), Courtesy of CIPA and Marks & Clerk (Team UPC)

    It's rather noteworthy that no matter how grim things have become for Team UPC, which drafted and promoted new laws for self-enrichment purposes, these people persist with all the same lies that predate several more barriers, which no doubt will prove fatal to the Unified Patent Court Agreement (UPCA)



  28. Links 1/12/2018: 4MLinux 27.0, GNU Wget 1.20 Released

    Links for the day



  29. EPO Management High-Fiving Patent Propaganda Sites Like 'Managing IP' While Granting Illegitimate Patents on Algorithms

    Having mastered the art of hype and buzzwords, the management of the EPO carries on pretending that it does nothing wrong by rubber-stamping abstract patents on mathematics



  30. “ILO Gave the EPO Medical Committee a Good Slapping”

    The Technical Centre for Agricultural and Rural Cooperation quits ILO (or its jurisdiction), whose tribunal has just released very few new decisions, only one of which regarding the EPO


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts